Arcalyst
List of products in the National Drug Code with proprietary name arcalyst. This medication is used to treat a certain group of inherited disorders called cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Rilonacept works by blocking a certain natural protein in your body (interleukin-1) that may worsen the symptoms of CAPS. Rilonacept does not cure CAPS, but it can help lessen the symptoms, including rash, joint pain, fever, and tiredness.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
73604-914 | Arcalyst | Rilonacept | Injection, Powder, Lyophilized, For Solution | Subcutaneous | Kiniksa Pharmaceuticals (uk), Ltd. | Human Prescription Drug |